- OUTRAGE: Big Pharma Ordered to Pay $70M After Concealing Adverse Effects of Cancer Drugs And Misleading Doctors
by Daniel Barker, http://www.naturalnews.com/
(NaturalNews) In a case that clearly illustrates the extent of corruption, callousness and greed on the part of Big Pharma’s cancer industry, two drug companies have been ordered to pay nearly $70 million to settle a federal lawsuit over charges that the companies lied about the effectiveness of a cancer drug.
The two companies, Genentech and OSI Pharmaceuticals, agreed to pay $67 million to avoid further litigation over its deceptive marketing of Tarceva, a drug used to treat non-small-cell lung cancer.
From the Los Angeles Times:
“The lawsuit claimed that from 2006 to 2011 Genentech and its marketing partner OSI Pharmaceuticals promoted Tarceva to treat all patients with non-small-cell lung cancer even though studies had shown that it worked for just those who had never smoked or had a certain gene mutation known as EGFR. Epidermal growth factor receptor is a type of protein found on the surface of cells in the body.”
A former Genentech employee, Brian Shields, filed the whistleblower suit in 2011 after his employers refused to acknowledge his concerns regarding the marketing of the ineffective drug. Shields said that he faced retaliation from his superiors after voicing his concerns and was told that he was not a “team player.”
Lies and bribes
Details of the lawsuit reveal the unscrupulous and illegal marketing techniques employed by the drug maker, which almost certainly led to the early deaths of patients who received treatment involving the useless drug.